Purchase Order 36C24226P0481
- Not listed
- Nuclear Diagnostic Products, Inc. has been awarded a delivery order valued at $959,170.05 for the supply of radiopharmaceuticals to Veterans Integrated Service Network 2 (VISN 2), a civilian healthcare network within the U.S. Department of Veterans Affairs. The contract, issued on February 24, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and carries no small business set-aside designation. The work will be performed in...
- Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, was awarded a $148,382.50 firm fixed-price purchase order by Veterans Integrated Service Network 4 (VISN 4) on March 15, 2026, for the supply of radiopharmaceuticals and calibration sources. The contract will be performed in Philadelphia, Pennsylvania, with a completion date of September 30, 2026. This award was made without a set-aside designation and represents a delivery order against the company's existing Indefinite...
- The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide general radiopharmaceuticals for the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in New York and New Jersey. This $610,950.85 contract has a completion date of February 21, 2024. Nuclear Diagnostic Products, Inc. is the prime contractor and has been awarded numerous similar contracts by the VA...
- Nuclear Diagnostic Products, Inc. was awarded a two-year, firm fixed price delivery order valued at approximately $1.9 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) to provide general radiopharmaceuticals. The contract has a period of performance starting February 22, 2021 through February 21, 2023, with all work to be conducted by the prime contractor at its facility located in Rockaway, New Jersey. No major...
- This delivery order, valued at $908,629, was awarded to Nuclear Diagnostic Products, Inc. by Veterans Integrated Service Network (VISN) 2, a civilian agency under the Department of Veterans Affairs, with a performance location in Rockaway, New Jersey. The award represents a modification to de-obligate unused fiscal year 2024 funds under an existing contract structure. Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, is a specialized supplier of radiopharmaceuticals to...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization that provides radiopharmaceuticals used in nuclear medicine procedures. The $288,366.34 contract is for the supply of radiopharmaceuticals to VA medical centers in Veterans Integrated Service Networks (VISNs) 2 and 4, which cover facilities in New York, New Jersey, Pennsylvania, and Delaware. The award is not set aside for any...
- This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization based in Rockaway, New Jersey. The contract is for the supply of radiopharmaceuticals, which are specialized medical imaging compounds used in nuclear medicine diagnostic procedures such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The contract has a ceiling value of $253,728.12 and is a...
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $174,071.55, is for the delivery of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. This contract is part of a larger Indefinite...
Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, has been awarded a total small business set-aside purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) for Pylarify (Piflufolastat F 18 Injection), a specialized radiopharmaceutical imaging agent used in positron emission tomography (PET) diagnostic procedures. The award, valued at $3.36 million on a firm fixed-price basis, was issued on April 2, 2026, with an ultimate completion date of April 1, 2027. The product will be delivered to VISN 2 Downstate Hospitals in the New York and New Jersey region to support nuclear medicine diagnostic imaging services for veterans across the VA healthcare system. This award stems from a market research sources sought notice posted in December 2025, through which VISN 2 sought to identify qualified suppliers of Pylarify classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). Nuclear Diagnostic Products, Inc. represents an established provider of radiopharmaceuticals to the VA, leveraging its existing radiopharmaceutical infrastructure and previous experience supplying diagnostic imaging compounds to VA medical facilities throughout the northeastern United States. The firm's award under the small business set-aside designation reflects its classification within the SBA's small business criteria and underscores the VA's commitment to supporting small business participation in critical healthcare supply contracts.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) (NDC 71258-0022-01) | 36C24226Q0246 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Pre-Solicitation 1/4 | 12/31/25, 8:30 AM | |
6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) Brand name or Equal | 36C24226Q0246 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Solicitation 3/4 | 3/5/26, 10:02 AM | |
6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) | 36C24226Q0246 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Award Notice 4/4 | 4/2/26, 3:58 PM | |
6505--RX - Brand name or Equal to Pylarify | 36C24226Q0246 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Pre-Solicitation 2/4 | 3/4/26, 3:50 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4m | 4/1/26 |